Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees.

  • Read more about Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees.

Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.

  • Read more about Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.

Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.

  • Read more about Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.

Zinc deficiency and its association with treatment-related toxicity in children with cancer.

  • Read more about Zinc deficiency and its association with treatment-related toxicity in children with cancer.

A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

  • Read more about A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Musculoskeletal impairments in children receiving intensive therapy for acute leukemia or undergoing hematopoietic stem cell transplant: A report from the Children's Oncology Group.

  • Read more about Musculoskeletal impairments in children receiving intensive therapy for acute leukemia or undergoing hematopoietic stem cell transplant: A report from the Children's Oncology Group.

Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.

  • Read more about Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.

Multimodality treatment including whole pleura radiation therapy for DICER1-associated pediatric pleuropulmonary blastoma.

  • Read more about Multimodality treatment including whole pleura radiation therapy for DICER1-associated pediatric pleuropulmonary blastoma.

Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.

  • Read more about Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.

Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.

  • Read more about Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.

Pagination

  • Previous page ‹‹
  • Page 6
  • Next page ››
Subscribe to Pediatric blood & cancer

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List